PROBLEM TO BE SOLVED: To provide: peptides, nucleic acids and cells for use in immunotherapeutic methods, in particular those relating to cancer； and tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides, that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses.SOLUTION: The present invention relates to more than 70 novel peptide sequences and their variants derived from HLA class I and HLA class II molecules isolated from human tumor cells.SELECTED DRAWING: NoneCOPYRIGHT: (C)2020,JPO&INPIT【課題】特にがんに関する、免疫療法で使用するためのペプチド、核酸、及び細胞の提供。さらには単独で、又はその他の腫瘍関連ペプチドとの組み合わせで、抗腫瘍免疫応答を刺激するワクチン組成物の活性医薬品成分の役割を果たす、腫瘍関連細胞傷害性Ｔ細胞（ＣＴＬ）ペプチドエピトープの提供。【解決手段】ヒト腫瘍細胞から単離したＨＬＡクラスＩ及びＨＬＡクラスＩＩ分子に由来する、７０個を超える新規ペプチド配列と、それらの変異型。【選択図】なし
